UGAL
List of publications resulting from the project
  1. Dragostin O., et al. Antioxidant Nanoparticles for Cancer Treatment: Obtaining and Biological Evaluation. 8th International Conference on Nanotechnology & Materials Science, April 24-26, 2019 Amsterdam, Netherlands;
  2. Dragostin OM, Dragostin I, Tatia R, Dragan M, Iacob A, Zamfir CL. New biocompatible isoniazid derivatives for the treatment of tuberculosis. 26th Young Research Fellows Meeting. Paris, France, 20 th-22 nd, 2019;
  3. Dragostin I, Dragostin OM, Dragan M, Stan CD, Zamfir CD. Drug Hypersensitivity Reduction Using Encapsulation Method with Chitosan-Cetirizine Derivatives. REV.CHIM.(Bucharest), (ISI, IF. 1,41), 2018, 69(12): 3731-3735;
  4. Dragostin I, Dragostin OM, Samal SK, Dash S, Tatia R, Dragan M, Confederat L, Ghiciuc CM, Diculencu D, Lupușoru CE, Zamfir CL. New Isoniazid Derivatives with Improved Pharmaco-Toxicological Profile: Obtaining, Characterization and Biological Evaluation. European Journal of Pharmaceutical Sciences, 2019, 137, 104974: 1-9. (ISI, IF. 3,8).
  5. Dragostin OM., Tatia R., et al. Designing of Chitosan Derivatives Nanoparticles with Antiangiogenic Effect for Cancer Therapy. Nanomaterials, 2020, 10, 698, (IF= 4.05) https://doi.org/10.3390/nano10040698
  6. Dragostin OM., Dragostin I., et al. New isoniazid derivatives for antimicrobial spectrum extension and hepatotoxicity reduction of parent compound: in vitro and in vivo assays. Farmacia, 2020, 68 (3): 532-540, (IF=1.52) https://doi.org/10.31925/farmacia.2020.3.20